Reaction

Oesophagopleural Fistula reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 32 reports · 3 co-occurring drugs

As of the last recalculation, Oesophagopleural Fistula appears in 32 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is GANCICLOVIR SODIUM (PRR 1,029.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ganciclovir Sodium111,029.71,030.8
Valganciclovir Hydrochloride Powder,121,023.31,024.3
Ganciclovir10923.9924.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.